article thumbnail

Global decentralized studies will become a standard clinical trial design approach

The Pharma Data

“These focus areas will materialize in study designs as hybrid decentralized approaches that support global programs,” Reites said. “In In 2021, technology-enabled clinical research with a more global focus will become a standard clinical design approach.”. Source link: [link].

article thumbnail

9th PREDiCT: Tumor Models Cell Therapy Summit

pharmaphorum

Join over 28 world-class speakers to see how classic and next-gen tumor models can be leveraged to expand your mechanism of action understanding, model the complexities of the tumor microenvironment, and guide your clinical design. Download the full event guide here for more information on what you can look forward to.

In-Vivo 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NHS pilots virtual assistant for flu jab bookings

pharmaphorum

Adding vaccination information, a self-service eligibility check, and booking functionality to Ask NHS lets patients, protect themselves and loved ones, quickly get the information they need and make appointments without having to call their clinic.

Nurses 74
article thumbnail

Common Pitfalls in Preparing an IND Application

Advarra

Using nonclinical data or manufacturing information that doesn’t adequately support the clinical protocol hurts the IND application. It’s critical to ensure all nonclinical data supports the clinical design and provides adequate justification of the desired labeling claims – including basic exposure data.